Repositioning of a Stakeholder Issue Applied at Pfizer Switzerland
| Author | : Georges Ulrich |
| Publisher | : Haupt Verlag AG |
| Total Pages | : 260 |
| Release | : 2009 |
| Genre | : |
| ISBN | : 325807514X |
Repositioning Of A Stakeholder Issue Applied At Pfizer Switzerland
Download Repositioning Of A Stakeholder Issue Applied At Pfizer Switzerland full books in PDF, epub, and Kindle. Read online free Repositioning Of A Stakeholder Issue Applied At Pfizer Switzerland ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Introduction to Business
| Author | : Lawrence J. Gitman |
| Publisher | : |
| Total Pages | : 1455 |
| Release | : 2024-09-16 |
| Genre | : Business & Economics |
| ISBN | : |
Introduction to Business covers the scope and sequence of most introductory business courses. The book provides detailed explanations in the context of core themes such as customer satisfaction, ethics, entrepreneurship, global business, and managing change. Introduction to Business includes hundreds of current business examples from a range of industries and geographic locations, which feature a variety of individuals. The outcome is a balanced approach to the theory and application of business concepts, with attention to the knowledge and skills necessary for student success in this course and beyond. This is an adaptation of Introduction to Business by OpenStax. You can access the textbook as pdf for free at openstax.org. Minor editorial changes were made to ensure a better ebook reading experience. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution 4.0 International License.
Global Business Regulation
| Author | : John Braithwaite |
| Publisher | : Cambridge University Press |
| Total Pages | : 194 |
| Release | : 2000-02-13 |
| Genre | : Business & Economics |
| ISBN | : 9780521780339 |
How has the regulation of business shifted from national to global institutions? What are the mechanisms of globalization? Who are the key actors? What of democratic sovereignty? In which cases has globalization been successfully resisted? These questions are confronted across an amazing sweep of the critical areas of business regulation--from contract, intellectual property and corporations law, to trade, telecommunications, labor standards, drugs, food, transport and environment. This book examines the role played by global institutions such as the World Trade Organization, World Health Organization, the OECD, IMF, Moodys and the World Bank, as well as various NGOs and significant individuals. Incorporating both history and analysis, Global Business Regulation will become the standard reference for readers in business, law, politics, and international relations.
Multi-stakeholder Governance and the Internet Governance Forum
| Author | : Jeremy Malcolm |
| Publisher | : Terminus Press |
| Total Pages | : 641 |
| Release | : 2008 |
| Genre | : Computers |
| ISBN | : 0980508401 |
"Multi-stakeholder governance is a fresh approach to the development of transnational public policy, bringing together governments, the private sector and civil society in partnership. The movement towards this new governance paradigm has been strongest in areas of public policy involving global networks of stakeholders, too intricate to be represented by governments alone. Nowhere is this better illustrated than on the Internet, where it is an inherent characteristic of the network that laws, and the behaviour to which those laws are directed, will cross national borders; resulting not only in conflicts between national regimes, but also running up against the technical and social architecture of the Internet itself. In this book, Jeremy Malcolm examines the new model of multi-stakeholder governance for the Internet regime that the Internet Governance Forum (IGF) represents. He builds a compelling case for the reform of the IGF to enable it to fulfil its mandate as an institution for multi-stakeholder Internet governance."--Provided by publisher.
Drug Repositioning
| Author | : Michael J. Barratt |
| Publisher | : John Wiley & Sons |
| Total Pages | : 499 |
| Release | : 2012-05-29 |
| Genre | : Medical |
| ISBN | : 0470878274 |
The how's and why's of successful drug repositioning Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy. Drug Repositioning is divided into three parts: Part 1, Drug Repositioning: Business Case, Strategies, and Operational Considerations, examines the medical and commercial drivers underpinning the quest to reposition existing drugs, guiding readers through the key strategic, technical, operational, and regulatory decisions needed for successful drug repositioning programs. Part 2, Application of Technology Platforms to Uncover New Indications and Repurpose Existing Drugs, sets forth computational-based strategies, tools, and databases that have been designed for repositioning studies, screening approaches, including combinations of existing drugs, and a look at the development of chemically modified analogs of approved agents. Part 3, Academic and Non-Profit Initiatives & the Role of Alliances in the Drug Repositioning Industry, explores current investigations for repositioning drugs to treat rare and neglected diseases, which are frequently overlooked by for-profit pharmaceutical companies due to their lack of commercial return. The book's appendix provides valuable resources for drug repositioning researchers, including information on drug repositioning and reformulation companies, databases, government resources and organizations, regulatory agencies, and drug repositioning initiatives from academia and non-profits. With this book as their guide, students and pharmaceutical researchers can learn how to use drug repositioning techniques to extend the lifespan and applications of existing drugs as well as maximize the return on investment in drug research and development.
Vessel Health and Preservation: The Right Approach for Vascular Access
| Author | : Nancy L. Moureau |
| Publisher | : Springer |
| Total Pages | : 303 |
| Release | : 2019-06-10 |
| Genre | : Medical |
| ISBN | : 3030031497 |
This Open access book offers updated and revised information on vessel health and preservation (VHP), a model concept first published in poster form in 2008 and in JVA in 2012, which has received a great deal of attention, especially in the US, UK and Australia. The book presents a model and a new way of thinking applied to vascular access and administration of intravenous treatment, and shows how establishing and maintaining a route of access to the bloodstream is essential for patients in acute care today. Until now, little thought has been given to an intentional process to guide selection, insertion and management of vascular access devices (VADs) and by default actions are based on crisis management when a quickly selected VAD fails. The book details how VHP establishes a framework or pathway model for each step of the patient experience, intentionally guiding, improving and eliminating risk when possible. The evidence points to the fact that reducing fragmentation, establishing a pathway, and teaching the process to all stakeholders reduces complications with intravenous therapy, improves efficiency and diminishes cost. As such this book appeals to bedside nurses, physicians and other health professionals.
Corporate Governance
| Author | : Robert A. G. Monks |
| Publisher | : Wiley-Blackwell |
| Total Pages | : 584 |
| Release | : 2003-12-19 |
| Genre | : Business & Economics |
| ISBN | : 9781405116985 |
In the wake of the dramatic series of corporate meltdowns: Enron; Tyco; Adelphia; WorldCom; the timely new edition of this successful text provides students and business professionals with a welcome update of the key issues facing managers, boards of directors, investors, and shareholders. In addition to its authoritative overview of the history, the myth and the reality of corporate governance, this new edition has been updated to include: analysis of the latest cases of corporate disaster; An overview of corporate governance guidelines and codes of practice in developing and emerging markets new cases: Adelphia; Arthur Andersen; Tyco Laboratories; Worldcom; Gerstner's pay packet at IBM Once again in the new edition of their textbook, Robert A. G. Monks and Nell Minow show clearly the role of corporate governance in making sure the right questions are asked and the necessary checks and balances in place to protect the long-term, sustainable value of the enterprise. A CD-ROM containing a comprehensive case study of the Enron collapse, complete with senate hearings and video footage, accompanies the text. Further lecturer resources and links are available at www.blackwellpublishing.com/monks
Organizational Theory, Design, and Change
| Author | : Gareth R. Jones |
| Publisher | : Pearson Prentice Hall |
| Total Pages | : 624 |
| Release | : 2006 |
| Genre | : Organizational behavior |
| ISBN | : 9780131245228 |
This book provides students with a clear, contemporary, and fully Canadian context for understanding Organizational Theory and Change. It explores many facets of Organizational Design, including the challenges presented by emerging new technologies and the global environment. It also addresses the key issues and problems that inform the process of organizational change and transformation, identifying direct and clear managerial implications.
New Health Technologies
| Author | : Collectif |
| Publisher | : OECD |
| Total Pages | : 239 |
| Release | : 2017-02-03 |
| Genre | : Social Science |
| ISBN | : 9264266445 |
This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money. The analysis considers how health systems and policy makers should adapt in terms of development, assessment and uptake of health technologies. The first chapter provides an examination of adoption and impact of medical technology in the past and how health systems are preparing for continuation of such trends in the future. Subsequent chapters examine the need to balance innovation, value, and access for pharmaceuticals and medical devices, respectively, followed by a consideration of their combined promise in the area of precision medicine. The final chapter examines how health systems can make better use of health data and digital technologies. The report focuses on opportunities linked to new and emerging technologies as well as current challenges faced by policy makers, and suggests a new governance framework to address these challenges.
Returning Individual Research Results to Participants
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 399 |
| Release | : 2018-08-23 |
| Genre | : Medical |
| ISBN | : 0309475201 |
When is it appropriate to return individual research results to participants? The immense interest in this question has been fostered by the growing movement toward greater transparency and participant engagement in the research enterprise. Yet, the risks of returning individual research resultsâ€"such as results with unknown validityâ€"and the associated burdens on the research enterprise are competing considerations. Returning Individual Research Results to Participants reviews the current evidence on the benefits, harms, and costs of returning individual research results, while also considering the ethical, social, operational, and regulatory aspects of the practice. This report includes 12 recommendations directed to various stakeholdersâ€"investigators, sponsors, research institutions, institutional review boards (IRBs), regulators, and participantsâ€"and are designed to help (1) support decision making regarding the return of results on a study-by-study basis, (2) promote high-quality individual research results, (3) foster participant understanding of individual research results, and (4) revise and harmonize current regulations.
